This page does not exist.

Click here to go back to the homepage


Latest news

COVID-19 – External Monitoring Guidelines

04th May 2020

Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing

Read more ›

Statement on COVID-19

23rd Mar 2020

Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are

Read more ›

First transdermal patch to treat schizophrenia hits market

18th Mar 2020

The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia

Read more ›

Cardiac Safety London

To help to enrich and speed up your drug development programs, join us for a day of discovery as global experts in

View event ›